Table 2 Osteoporosis therapy background by study group
Variable | Study group by BMD | |||
|---|---|---|---|---|
Severe osteoporosis with prior BF (n = 272) | Osteoporosis (n = 1958) | T-score > −2.5 (n = 552) | F or Chi-2(p value)₤ | |
Osteoporosis therapy (%) | ||||
Hygiene/health measures | 90.9 | 91.4 | 89.6 | 1.4 (p = 0.489) |
Calcium supplement | 12.2 | 10.4 | 14.5 | 5.6 (p = 0.062) |
Calcium + vitamin D | 80.0 | 81.9 | 72.7 | 16.8 (p < 0.001) |
Exercise | 45.2 | 42.3 | 42.3 | 0.7 (p = 0.694) |
Biphosphonates | 61.7 | 49.0 | 43.5 | 19.1 (p < 0.001) |
SERM | 26.5 | 42.3 | 47.1 | 26.3 (p < 0.001) |
Other drug therapy | 12.2 | 7.0 | 5.5 | 10.0 (p = 0.007) |